Amid rising cases of Coronavirus infection in India and some companies reporting various kinds of success in Coronavirus vaccine trials, it has become important for investors to know how these reports will impact markets or they will end up losing their money. Explaining how such COVID-19 pandemic news is impacting the markets, Zee Business Managing Editor Anil Singhvi said that till a vaccine is actually developed, these kind of reports have become a non-event for the current markets. Stocks will neither go upward or downward due to this.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Dubbing Coronavirus related news as a non-event for the current markets, Anil Singhvi said, "Currently, Coronavirus related news have become a non-event for the markets. When I say non-event, I mean both positive and negative news. Recently, Moderna claimed success in third stage COVID-19 vaccine trials but the market didn't react too much on that and similarly, the market has gone non-reactive on the huge number of new Corona cases being reported on day to day basis." 

The Market Guru said that the market is well aware that in a few months, Coronavirus vaccine is coming and hence there is no need to panic from the rising cases and at the same time there is no need to cheer announcement of small successes in vaccine development because there is still a long way to go in fighting this disease.

See Zee Business Live TV streaming below:

On how the markets will react when the Coronavirus vaccine is developed, Singhvi said, "When the Coronavirus vaccine will be developed, then it's for sure that bulls will have a huge run on various streets globally." 

He said that Coronavirus vaccine development will be a concrete news and nothing will get changed once the vaccine is produced. So, it will be a strong fundamental news for the markets globally and markets are bound to respond positively on that big news.